BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 25130465)

  • 1. Differential impact of glucose levels and advanced glycation end-products on tubular cell viability and pro-inflammatory/profibrotic functions.
    Franko B; Brault J; Jouve T; Beaumel S; Benhamou PY; Zaoui P; Stasia MJ
    Biochem Biophys Res Commun; 2014 Sep; 451(4):627-31. PubMed ID: 25130465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
    Maeda S; Matsui T; Takeuchi M; Yamagishi S
    Diabetes Metab Res Rev; 2013 Jul; 29(5):406-12. PubMed ID: 23508966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).
    Oldfield MD; Bach LA; Forbes JM; Nikolic-Paterson D; McRobert A; Thallas V; Atkins RC; Osicka T; Jerums G; Cooper ME
    J Clin Invest; 2001 Dec; 108(12):1853-63. PubMed ID: 11748269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.
    Liu J; Huang K; Cai GY; Chen XM; Yang JR; Lin LR; Yang J; Huo BG; Zhan J; He YN
    Cell Signal; 2014 Jan; 26(1):110-21. PubMed ID: 24113348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells.
    Liang YJ; Jian JH; Liu YC; Juang SJ; Shyu KG; Lai LP; Wang BW; Leu JG
    Diabetes Metab Res Rev; 2010 Jul; 26(5):406-16. PubMed ID: 20583309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro-prepared advanced glycation end-products and the modulating potential of their low-molecular weight degradation products in IRPTC-A rat proximal-tubular derived kidney epithelial cell line.
    Deuther-Conrad W; Franke S; Henle T; Sommer M; Stein G
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL187-96. PubMed ID: 11936867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus.
    Lim M; Park L; Shin G; Hong H; Kang I; Park Y
    Ann N Y Acad Sci; 2008 Dec; 1150():311-5. PubMed ID: 19120318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
    Morcos M; Schlotterer A; Sayed AA; Kukudov G; Oikomonou D; Ibrahim Y; Pfisterer F; Schneider J; Bozorgmehr F; Rudofsky G; Schwenger V; Kientsch-Engels R; Hamann A; Zeier M; Dugi K; Yard B; Humpert PM; van der Woude F; Nawroth PP; Bierhaus A
    Horm Metab Res; 2008 Nov; 40(11):752-9. PubMed ID: 18711692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
    Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
    Biochem Biophys Res Commun; 2010 Jul; 398(2):326-30. PubMed ID: 20599709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
    Kume S; Kato S; Yamagishi S; Inagaki Y; Ueda S; Arima N; Okawa T; Kojiro M; Nagata K
    J Bone Miner Res; 2005 Sep; 20(9):1647-58. PubMed ID: 16059636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes.
    Han D; Yamamoto Y; Munesue S; Motoyoshi S; Saito H; Win MT; Watanabe T; Tsuneyama K; Yamamoto H
    Genes Cells; 2013 Apr; 18(4):302-14. PubMed ID: 23410183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells.
    Huang JS; Chuang LY; Guh JY; Huang YJ; Hsu MS
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1072-82. PubMed ID: 17596533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy.
    Brizzi MF; Dentelli P; Rosso A; Calvi C; Gambino R; Cassader M; Salvidio G; Deferrari G; Camussi G; Pegoraro L; Pagano G; Cavallo-Perin P
    FASEB J; 2004 Aug; 18(11):1249-51. PubMed ID: 15180953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytoestrogen calycosin-7-O-β-D-glucopyranoside ameliorates advanced glycation end products-induced HUVEC damage.
    Xu Y; Feng L; Wang S; Zhu Q; Lin J; Lou C; Xiang P; He B; Zheng Z; Tang D; Zuo G
    J Cell Biochem; 2011 Oct; 112(10):2953-65. PubMed ID: 21647942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mesangial cells resist glycoxidative stress through an antioxidant response.
    Nitti M; Furfaro AL; Patriarca S; Balbis E; Domenicotti C; Cottalasso D; Pronzato MA; Marinari UM; Traverso N
    Int J Mol Med; 2011 Feb; 27(2):213-9. PubMed ID: 21152865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases.
    Allen DA; Harwood S; Varagunam M; Raftery MJ; Yaqoob MM
    FASEB J; 2003 May; 17(8):908-10. PubMed ID: 12670885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of high glucose and AGEs on cultured kidney-derived cells. Effects on cell viability, lysosomal enzymes and effectors of cell signaling pathways.
    Peres GB; Schor N; Michelacci YM
    Biochimie; 2017 Apr; 135():137-148. PubMed ID: 28229902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant lysozyme downregulates advanced glycation endproduct-induced interleukin-6 production and release in an in-vitro model of human proximal tubular epithelial cells.
    Gallo D; Cocchietto M; Masat E; Agostinis C; Harei E; Veronesi P; Sava G
    Exp Biol Med (Maywood); 2014 Mar; 239(3):337-46. PubMed ID: 24495950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.